From Military Service to Tinnitus: A Veteran's Guide to Treatment Options

Tinnitus is the number one disability claim in the Veterans Affairs system. Not PTSD. Not musculoskeletal injuries. Not traumatic brain injury. Tinnitus. Over 2.3 million veterans receive VA disability compensation for service-connected tinnitus, and the number grows every year.

The reasons are straightforward: military service involves sustained exposure to some of the loudest environments humans encounter. Weapons fire ranges from 140 to 190 dB — well above the 85 dB threshold for hearing damage. Improvised explosive devices produce blast waves that damage cochlear structures through both acoustic overpressure and physical concussive force. Armored vehicle engines, aircraft, and naval machinery create chronic noise exposure that compounds over years of service.

But the military tinnitus crisis is more complex than noise exposure alone. Traumatic brain injury (TBI), common in post-9/11 combat veterans, damages auditory processing pathways independent of cochlear injury. Ototoxic medications — including certain antibiotics, anti-malarials, and NSAIDs commonly used in field medicine — contribute to hair cell damage. The high rates of PTSD in combat veterans create a neurological environment where tinnitus is more likely to become chronic and distressing: veterans with PTSD are 17 times more likely to screen positive for severe tinnitus.

The VA spends approximately $2.26 billion annually on tinnitus-related disability compensation and care. Despite this enormous expenditure, the treatment options available through the VA remain limited — and many veterans feel underserved.

The VA's primary tinnitus intervention is the Progressive Tinnitus Management (PTM) program, a structured approach developed by VA researchers James Henry and Paula Myers. PTM is a five-level system that triages veterans based on severity and provides increasingly intensive interventions.

Level 1 is triage: an audiological evaluation and basic counseling. Level 2 provides audiology services including hearing aids (which can reduce tinnitus by amplifying ambient sound and reducing central gain) and sound therapy devices. Level 3 involves group education workshops. Level 4 offers individualized interdisciplinary evaluation. Level 5 provides referral to specialized mental health services for veterans with comorbid psychological conditions.

Cognitive behavioral therapy for tinnitus (CBT-T) is the most evidence-supported psychological intervention. It does not aim to eliminate the tinnitus sound — it aims to change the brain's emotional and attentional response to it. A 2025 Cochrane review confirmed CBT as effective for reducing tinnitus-related distress, anxiety, and depressive symptoms. The VA has increasingly incorporated CBT-T into its tinnitus programs.

Sound therapy encompasses a range of approaches: masking (covering the tinnitus with external sound), habituation-based therapy (using low-level sound to promote neuroplastic adaptation), and notched sound therapy (removing the tinnitus frequency from sound stimuli to induce competitive plasticity in the auditory cortex). The VA provides hearing aids with integrated sound generators for eligible veterans.

These approaches help many veterans manage their tinnitus — but they are fundamentally management strategies, not cures. They do not address the underlying cochlear damage or the maladaptive neural patterns that generate the phantom sound.

The treatment landscape for tinnitus is expanding beyond what the VA currently offers, though most emerging interventions remain in clinical trials or early adoption.

Lenire, developed by Neuromod Devices, is the first FDA-cleared bimodal neuromodulation device for tinnitus. It combines electrical stimulation of the tongue (via a proprietary mouthpiece) with precisely timed acoustic stimulation delivered through headphones. The dual stimulation targets the dorsal cochlear nucleus — a brainstem structure where auditory and somatosensory signals converge — aiming to desynchronize the aberrant neural activity that produces tinnitus. A large-scale clinical trial (TENT-A3) showed clinically meaningful improvement in tinnitus severity for a significant proportion of participants. Lenire is available by prescription but is not yet widely offered through the VA.

Transcranial magnetic stimulation (TMS) applies focused magnetic pulses to specific brain regions, modulating neural activity. When applied to the temporoparietal junction (the cortical region overlying the auditory cortex), TMS can temporarily reduce tinnitus loudness and distress. Some VA medical centers offer TMS for depression and are exploring its application for tinnitus.

Regenerative approaches — including stem cell therapy and gene therapy targeting cochlear hair cell regeneration — represent the most ambitious path forward. The March 2025 discovery of a new DNA enhancer active only in cochlear supporting cells opens a precise targeting mechanism for gene therapy delivery. These approaches are in preclinical and early clinical stages but represent the possibility of actual repair rather than symptom management.

Peptide therapy, while not specific to tinnitus, addresses relevant pathways. BPC-157 and TB-500 support nerve repair and reduce neuroinflammation — processes relevant to the auditory nerve damage that contributes to many tinnitus cases. TB-500's ability to cross the blood-brain barrier gives it potential access to central auditory structures.

The relationship between PTSD and tinnitus in veteran populations is not coincidental — it is neurobiological. Both conditions involve maladaptive neural plasticity, limbic system dysregulation, and impaired prefrontal cortex gating of unwanted signals.

In PTSD, the amygdala is hyperactive, generating threat responses to stimuli that are not actually dangerous. The prefrontal cortex, which should inhibit these false alarms, is underactive. The result is hypervigilance, intrusive memories, and emotional reactivity that the veteran cannot voluntarily suppress.

In tinnitus, the auditory cortex generates a phantom signal. The limbic system assigns emotional significance to it (distress, anxiety, frustration). The prefrontal cortex, which should gate the signal out of conscious awareness, fails to do so. The result is a sound the veteran cannot voluntarily ignore.

The parallel is not metaphorical — it is structural. Both conditions involve the same brain regions, the same neurotransmitter systems (serotonin, norepinephrine, GABA), and the same failure of top-down cortical inhibition. This is why veterans with PTSD are 17 times more likely to have severe tinnitus: the same neural vulnerability underlies both conditions.

This comorbidity has treatment implications. Interventions that address the shared neural substrate — particularly those that restore prefrontal cortex function and reduce limbic hyperactivation — may benefit both conditions simultaneously. This is part of the rationale behind psychedelic-assisted therapy research: psilocybin's documented effects on the default mode network and limbic-cortical connectivity address mechanisms relevant to both PTSD and tinnitus.

For veterans seeking help with service-connected tinnitus, understanding the VA system is essential for accessing available resources.

Service connection for tinnitus requires demonstrating that the condition is related to military service. This typically involves an audiological evaluation, documentation of noise exposure during service, and a nexus statement from a healthcare provider linking the tinnitus to service. The current VA disability rating for tinnitus is 10% — a figure that many veterans and advocates argue is insufficient given the condition's impact on quality of life.

Veterans should request referral to a VA audiologist specifically trained in tinnitus management. Not all VA audiologists have specialized tinnitus training, and the quality of care varies significantly between facilities. The VA's Progressive Tinnitus Management program is available at many VA medical centers but is not uniformly implemented.

Hearing aids through the VA are provided at no cost for service-connected hearing conditions and can significantly reduce tinnitus perception by amplifying ambient sound. Modern VA hearing aids often include integrated sound therapy features.

Veterans interested in emerging treatments like neuromodulation, peptide therapy, or regenerative approaches should be aware that these are generally not available through the VA system and would require out-of-pocket expenditure through private providers. ExtraLife works with veterans seeking access to regenerative and peptide-based approaches, with protocols tailored to the specific patterns of auditory and neurological injury common in military service.

Veteran-specific resources include the VA's National Center for Rehabilitative Auditory Research (NCRAR), the Hearing Health Foundation's veteran programs, and organizations like the Wounded Warrior Project that can help navigate benefits and treatment options.

ExtraLife was founded with a deep commitment to the veteran community that bears a disproportionate burden of tinnitus. Our three-pillar research approach — stem cells, peptides, and psychedelic-assisted neuroplasticity — is designed with military-related tinnitus specifically in mind.

The blast-induced tinnitus common in post-9/11 veterans involves both peripheral cochlear damage and central nervous system injury from TBI. This dual-injury pattern requires a dual approach: repair of the damaged hardware (cochlear structures and auditory nerves) combined with rewiring of the maladaptive software (central neural patterns maintaining the phantom sound).

Our planned pilot study will prioritize veteran participants — the population with the greatest need and the most to gain from effective treatment. We are working within established research frameworks and seeking appropriate regulatory approvals.

The veterans who served this country deserve more than sound masking and coping strategies. They deserve research aimed at actual solutions. That is what ExtraLife Hearing is building — transparently, rigorously, and with the urgency the crisis demands.